Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rimantadine Hydrochloride Granules

Approval Number

国药准字H20100029

Company金陵药业股份有限公司南京金陵制药厂

Registration Date

February 26, 2020

Drug Information

Generic Name

盐酸金刚乙胺颗粒

Dosage Form

颗粒剂

Strength

0.1g(以盐酸金刚乙胺计)

Drug Type

化学药品

Registration Date

February 26, 2020

Company Information

Applicant Company

Company Name金陵药业股份有限公司南京金陵制药厂

Company Address

南京经济技术开发区新港大道58号

Manufacturing Company

Company Name金陵药业股份有限公司南京金陵制药厂

Company Address

南京经济技术开发区新港大道58号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy